Schizophrenia
Conditions
Keywords
Executive function, Meta-cognition, Schizophrenia, Meta-cognitive intervention
Brief summary
The overall aim of this study was to develop a meta-cognitive group intervention in order to apply it and to understand and distinguish the components that influence participation among people with schizophrenia
Detailed description
The overall aim of this study was to develop a Meta cognitive group intervention in order to apply it and to understand and distinguish the components that influence participation among people with schizophrenia. The specific objectives were to: 1. Improve participation by increasing the effectiveness of cognitive strategy use and teaching clients to independently review performance and to examine the strategy's effectiveness. 2. Compare the use of cognitive strategies between participants with schizophrenia and their matched controls following the Meta cognitive group intervention and to correlate the cognitive strategies use and participation following the Meta cognitive group. 3. Examine whether symptoms moderate the association between metacognitive outcomes and participation among people with schizophrenia following the Meta cognitive group.
Interventions
BEHAVIORALMetacognitive Group Intervention
The investigators developed an initial Meta cognitive group intervention protocol based on the dynamic interactional model of cognition (Toglia, 2005), and specifically tailored it to individuals with schizophrenia.
BEHAVIORALOccupational therapy standard care
Occupational therapy standard care
Sponsors
University of Haifa
Study design
Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)
Intervention model description
Before and after intervention
Eligibility
Sex/Gender
ALL
Age
23 Years to 68 Years
Healthy volunteers
No
Inclusion criteria
* Confirmed diagnosis of schizophrenia by a licensed psychiatrist * Fluency in Hebrew * t-score of at least 65 on the Behavior Rating Inventory of Executive Function-Adult version
Exclusion criteria
* Severe psychiatric hospitalization of over 24 hours during the month prior to the beginning of the study * Used drugs or alcohol
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Positive and Negative Syndrome Scale | 15 minutes | The Positive and Negative Syndrome Scale is a 30-item scale with seven positive and seven negative symptoms items and 16 psychopathological items. The severity of each item is rated on a scale from 1 (none) to 7 (most severe). A general Positive and Negative Syndrome Scale score is between 30 (lack of symptoms) and 210 (very severe state of the disease). Potential ranges are 7 to 49 for the positive and negative symptom scales and from 16 to 12 for the general psychopathology scale. |
Outcome results
None listed